With the latest approval, Vertex's Kaftrio is now eligible to treat about 4,000 people living in the EU with rare mutations ...

The European Commission (EC) has granted approval for AstraZeneca's Imfinzi plus chemotherapy for treating resectable NSCLC ...

Accord received a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use for ...

The European Commission approves AstraZeneca's Enhertu for a new breast cancer indication while also expanding Imfinzi label ...

EU approves expanded use of ABBV's Rinvoq and AZN's Imfinzi and Enhertu. NVS set to invest $23B to boost U.S. manufacturing.

Find out how Bristol Myers Squibb was honored for 50 years of service in Lawrence, from local support to global medical ...

CERN’s LHCb experiment confirms CP violation in baryons, marking a milestone in particle physics; Japan unveils the world’s ...

Johnson & Johnson (J&J) has announced that Stelara (ustekinumab) has been approved by the European Commission (EC) to treat ...

The Physicians Committee for Responsible Medicine, a nonprofit that advocates for nonanimal science, is applauding the new ...

The term „Unmet Need“ is used multiple times in EU HTA regulations, the EU pharmaceutical legislation and in HTA guidelines.